189 related articles for article (PubMed ID: 21429745)
1. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
[TBL] [Abstract][Full Text] [Related]
2. 4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacy.
Liddle J; Bamborough P; Barker MD; Campos S; Chung CW; Cousins RP; Faulder P; Heathcote ML; Hobbs H; Holmes DS; Ioannou C; Ramirez-Molina C; Morse MA; Osborn R; Payne JJ; Pritchard JM; Rumsey WL; Tape DT; Vicentini G; Whitworth C; Williamson RA
Bioorg Med Chem Lett; 2012 Aug; 22(16):5222-6. PubMed ID: 22801646
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors.
Caldarelli M; Angiolini M; Disingrini T; Donati D; Guanci M; Nuvoloni S; Posteri H; Quartieri F; Silvagni M; Colombo R
Bioorg Med Chem Lett; 2011 Aug; 21(15):4507-11. PubMed ID: 21723120
[TBL] [Abstract][Full Text] [Related]
4. A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit.
Cushing TD; Baichwal V; Berry K; Billedeau R; Bordunov V; Broka C; Cardozo M; Cheng P; Clark D; Dalrymple S; DeGraffenreid M; Gill A; Hao X; Hawley RC; He X; Jaen JC; Labadie SS; Labelle M; Lehel C; Lu PP; McIntosh J; Miao S; Parast C; Shin Y; Sjogren EB; Smith ML; Talamas FX; Tonn G; Walker KM; Walker NP; Wesche H; Whitehead C; Wright M; Browner MF
Bioorg Med Chem Lett; 2011 Jan; 21(1):417-22. PubMed ID: 21074993
[TBL] [Abstract][Full Text] [Related]
5. The discovery and initial optimisation of pyrrole-2-carboxamides as inhibitors of p38alpha MAP kinase.
Down K; Bamborough P; Alder C; Campbell A; Christopher JA; Gerelle M; Ludbrook S; Mallett D; Mellor G; Miller DD; Pearson R; Ray K; Solanke Y; Somers D
Bioorg Med Chem Lett; 2010 Jul; 20(13):3936-40. PubMed ID: 20570148
[TBL] [Abstract][Full Text] [Related]
6. The discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors.
Buckmelter AJ; Ren L; Laird ER; Rast B; Miknis G; Wenglowsky S; Schlachter S; Welch M; Tarlton E; Grina J; Lyssikatos J; Brandhuber BJ; Morales T; Randolph N; Vigers G; Martinson M; Callejo M
Bioorg Med Chem Lett; 2011 Feb; 21(4):1248-52. PubMed ID: 21211972
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 6-aryl-7-alkoxyisoquinoline inhibitors of IkappaB kinase-beta (IKK-beta).
Christopher JA; Bamborough P; Alder C; Campbell A; Cutler GJ; Down K; Hamadi AM; Jolly AM; Kerns JK; Lucas FS; Mellor GW; Miller DD; Morse MA; Pancholi KD; Rumsey W; Solanke YE; Williamson R
J Med Chem; 2009 May; 52(9):3098-102. PubMed ID: 19348415
[TBL] [Abstract][Full Text] [Related]
8. The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
Cowley PM; Baker J; Barn DR; Buchanan KI; Carlyle I; Clark JK; Clarkson TR; Deehan M; Edwards D; Goodwin RR; Jaap D; Kiyoi Y; Mort C; Palin R; Prosser A; Walker G; Ward N; Wishart G; Young T
Bioorg Med Chem Lett; 2011 Jan; 21(1):497-501. PubMed ID: 21075628
[TBL] [Abstract][Full Text] [Related]
9. Discovery and optimization of pyrazoline compounds as B-Raf inhibitors.
Duffey MO; Adams R; Blackburn C; Chau RW; Chen S; Galvin KM; Garcia K; Gould AE; Greenspan PD; Harrison S; Huang SC; Kim MS; Kulkarni B; Langston S; Liu JX; Ma LT; Menon S; Nagayoshi M; Rowland RS; Vos TJ; Xu T; Yang JJ; Yu S; Zhang Q
Bioorg Med Chem Lett; 2010 Aug; 20(16):4800-4. PubMed ID: 20634068
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase.
Kempson J; Guo J; Das J; Moquin RV; Spergel SH; Watterson SH; Langevine CM; Dyckman AJ; Pattoli M; Burke JR; Yang X; Gillooly KM; McIntyre KW; Chen L; Dodd JH; McKinnon M; Barrish JC; Pitts WJ
Bioorg Med Chem Lett; 2009 May; 19(10):2646-9. PubMed ID: 19376699
[TBL] [Abstract][Full Text] [Related]
11. Optimization of alpha-ketoamide based p38 inhibitors through modifications to the region that binds to the allosteric site.
Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Ernst JT; Gibbs A; Kahl J; Kessler L; Kucharski J; Lum C; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Urban J; Wang Z; Larson CJ
Bioorg Med Chem Lett; 2010 Aug; 20(16):4819-24. PubMed ID: 20663667
[TBL] [Abstract][Full Text] [Related]
12. Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: improvement of potency in vitro and in vivo.
Shimizu H; Yasumatsu I; Hamada T; Yoneda Y; Yamasaki T; Tanaka S; Toki T; Yokoyama M; Morishita K; Iimura S
Bioorg Med Chem Lett; 2011 Feb; 21(3):904-8. PubMed ID: 21232950
[TBL] [Abstract][Full Text] [Related]
13. A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogs.
Cushing TD; Baichwal V; Berry K; Billedeau R; Bordunov V; Broka C; Browner MF; Cardozo M; Cheng P; Clark D; Dalrymple S; DeGraffenreid M; Gill A; Hao X; Hawley RC; He X; Labadie SS; Labelle M; Lehel C; Lu PP; McIntosh J; Miao S; Parast C; Shin Y; Sjogren EB; Smith ML; Talamas FX; Tonn G; Walker KM; Walker NP; Wesche H; Whitehead C; Wright M; Jaen JC
Bioorg Med Chem Lett; 2011 Jan; 21(1):423-6. PubMed ID: 21074992
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.
Nishiguchi GA; Atallah G; Bellamacina C; Burger MT; Ding Y; Feucht PH; Garcia PD; Han W; Klivansky L; Lindvall M
Bioorg Med Chem Lett; 2011 Nov; 21(21):6366-9. PubMed ID: 21945284
[TBL] [Abstract][Full Text] [Related]
15. 5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinase.
Bamborough P; Christopher JA; Cutler GJ; Dickson MC; Mellor GW; Morey JV; Patel CB; Shewchuk LM
Bioorg Med Chem Lett; 2006 Dec; 16(24):6236-40. PubMed ID: 16997559
[TBL] [Abstract][Full Text] [Related]
16. Kinase array design, back to front: biaryl amides.
Baldwin I; Bamborough P; Haslam CG; Hunjan SS; Longstaff T; Mooney CJ; Patel S; Quinn J; Somers DO
Bioorg Med Chem Lett; 2008 Oct; 18(19):5285-9. PubMed ID: 18789685
[TBL] [Abstract][Full Text] [Related]
17. Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: exploration of effective compounds in arthritis models.
Shimizu H; Yamasaki T; Yoneda Y; Muro F; Hamada T; Yasukochi T; Tanaka S; Toki T; Yokoyama M; Morishita K; Iimura S
Bioorg Med Chem Lett; 2011 Aug; 21(15):4550-5. PubMed ID: 21705219
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.
Selness SR; Devraj RV; Monahan JB; Boehm TL; Walker JK; Devadas B; Durley RC; Kurumbail R; Shieh H; Xing L; Hepperle M; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R
Bioorg Med Chem Lett; 2009 Oct; 19(20):5851-6. PubMed ID: 19751974
[TBL] [Abstract][Full Text] [Related]
19. Discovery and structure-activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2.
Fuchi N; Iura Y; Kaneko H; Nitta A; Suyama K; Ueda H; Yamaguchi S; Nishimura K; Fujii S; Sekiya Y; Yamada M; Takahashi T
Bioorg Med Chem Lett; 2012 Jul; 22(13):4358-61. PubMed ID: 22633690
[TBL] [Abstract][Full Text] [Related]
20. Design of potent IGF1-R inhibitors related to bis-azaindoles.
Nemecek C; Metz WA; Wentzler S; Ding FX; Venot C; Souaille C; Dagallier A; Maignan S; Guilloteau JP; Bernard F; Henry A; Grapinet S; Lesuisse D
Chem Biol Drug Des; 2010 Aug; 76(2):100-6. PubMed ID: 20545947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
